InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
3
T+90 hit rate
73%
T+90 mean return
+6.5%
Across 11 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Elsbernd Brian, Directeur de la Conformité. Director active across 1 company, notably Catalyst Pharmaceuticals, INC.. Cumulatively, 21 reports have been logged. Split: 0 buy · 3 sells. Total volume traded: €1.4m. History available since 11 November 2022. The latest transaction was disclosed on 12 November 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations21 total
6,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000491:0
2,623 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000491:1
7,067 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000445:0
5,161 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000416:0
▼
40,000 shares@ US$22.7040.9% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-25-000374:0
◇
112,475 shares@ US$2.2418.9% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-25-000320:0
20,000 shares@ US$2.243.4% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-25-000318:0
9,270 shares@ US$2.242.3% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-25-000085:0
9,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-25-000067:0
6,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000539:0
1,941 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000539:1
7,067 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000501:0
◇
50,244 shares@ US$4.0122.0% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-24-000490:0
▼
25,000 shares@ US$16.4443.2% of flowCommon stock, par value $0.001 per shareSEC:0001161697-24-000164:0
9,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-24-000100:0
6,666 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000645:0
50,000 shares@ US$1.136.0% of flowCommon Stock, par value $0.001 per shareSEC:0001161697-23-000173:0
9,666 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-23-000127:0
14,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-22-000572:0
▼
14,666 shares@ US$16.23526.6% of flowCommon stock, par value $0.001 per shareSEC:0001161697-22-000549:0
14,667 sharesCommon Stock, par value $0.001 per shareSEC:0001161697-21-000561:0
21 of 21 declarations
About Elsbernd Brian
Brian Elsbernd serves as Chief Compliance/Legal Officer of Catalyst Pharmaceuticals, Inc. In this role, he is responsible for managing the company's legal affairs and regulatory compliance. Brian plays a crucial role in protecting the company's legal interests and guiding strategic legal decisions. His expertise in business law is a significant asset for Catalyst Pharmaceuticals.
